New Delhi, Dec 12 (PTI) The government has constituted a committee to review and revise the ceiling rates for various implants admissible under the Central Government Health Scheme, Union Health Minister Mansukh Mandaviya said on Tuesday.

Responding to a question in the Rajya Sabha, Mandaviya said deep brain stimulation surgery for Parkinson's diseases is a listed procedure under the Central Government Health Scheme and treatment can be undertaken from hospitals empanelled under the scheme.

Also Read | Uttar Pradesh: Class 12 Boy Suspended Over Objectionable Comments Against Holy Prophet Muhammad in Aligarh.

Mandaviya said permission for one deep brain stimulation implant was granted on November 1 for treatment at Delhi's BLK-Max Hospital. Permission for another implant procedure was granted on June 15, 2021, for treatment at NIMS-Hyderabad.

Permission for battery replacement was granted for three cases on June 15, 2021; January 7, 2022; and April 13, 2022, at NIMS-Hyderabad.

Also Read | Japan's Oldest Person Dies: Fusa Tatsumi, Passes at Age of 116 in Osaka Prefecture.

The rates for deep brain stimulation implants were notified through an office memorandum dated December 4, 2008.

These rates were further revalidated in December 2014 and July 2018.

"The government has constituted a committee to review and revise the ceiling rates for the various implants, admissible under Central Government Health Scheme, including deep brain stimulation implants and battery," he said.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)